Kiss Goodbye to Multiple Sclerosis (MS) : Searching For A Cure

In this segment, MS Research Australia’s CEO Dr. Matthew Miles joins the program to promote the global campaign “Kiss Goodbye to MS.” It’s a national initiative by MS Research Australia focused on raising critical funds for Australian MS research. He talks about the importance of raising funds for MS research due to the fact there is still no cure for it yet. He also discusses about his genuine desire to help those with this condition.

Dr. Matthew Miles is the Chief Executive Officer of MS Research Australia, reporting to the Board of Directors. He has extensive leadership, executive management, media, finance, marketing, operations, sponsorship and fundraising experience. He is a Fellow of the Australian Institute of Managers and a Graduate of the Australian Institute of Company Directors. He has a post graduate Master’s (MBA) degree from the Australian Graduate School of Management (AGSM) at UNSW. Matthew has a Bachelor of Veterinary Science undergraduate degree from the University of Queensland, and has significant experience in different areas of medical and veterinary research as well as education at tertiary level. Prior to joining MS Research Australia, Matthew was at UNSW Australia as the inaugural Director of the Office of Development and External Relations overseeing a wide portfolio. He was the recipient of a Commonwealth Government “Inspiring Australia” award in 2010 as well as a “NSW State Government Science Discovery” award. In 2010, he received the prestigious award for Outstanding Contribution to UNSW Medicine and was twice shortlisted for the University Award (2010, 2012). In 2013, he was bestowed with honorary alumnus status to UNSW Medicine. In 2015, he was awarded the coveted Harvard Club of Australia Fellowship, attending Harvard University as a not-for-profit Fellow. Matthew is a Board Director of the MS International Federation (MSIF) and an Executive Committee member of the Global Progressive MS Alliance.

0 Comments

Leave a Reply

You must be logged in to post a comment.